These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 3516408)
21. Dosing and administration of ergotamine tartrate and dihydroergotamine. Mathew NT Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471 [TBL] [Abstract][Full Text] [Related]
22. Cluster headache: trial of a combined histamine H1 and H2 antagonist treatment. Russell D J Neurol Neurosurg Psychiatry; 1979 Jul; 42(7):668-9. PubMed ID: 479908 [TBL] [Abstract][Full Text] [Related]
23. [Clinical study of dihydroergotamine (DHE-45). 1. Effect in the treatment of vascular headache. 2. Effect on stellate ganglion block]. Miyazaki T; Kamiyama Y; Kitajima T; Onda M Masui; 1976 Jan; 25(1):65-70. PubMed ID: 943589 [No Abstract] [Full Text] [Related]
24. [Treatment of cluster headache (author's transl)]. Pfaffenrath V; Prosiegel M; Neu I MMW Munch Med Wochenschr; 1982 Mar; 124(12):293-6. PubMed ID: 6804810 [No Abstract] [Full Text] [Related]
25. Prevention of migraine attacks through the use of dihydroergotamine. Neuman M; Demarez JP; Harmey JL; Le Bastard B; Cauquil J Int J Clin Pharmacol Res; 1986; 6(1):11-3. PubMed ID: 3514491 [TBL] [Abstract][Full Text] [Related]
26. [Migraine: dihydroergotamine nasal spray--an alternative]. Beubler E Wien Med Wochenschr; 1995; 145(14):326-31. PubMed ID: 7483646 [TBL] [Abstract][Full Text] [Related]
27. The treatment of cluster headache with repetitive intravenous dihydroergotamine. Mather PJ; Silberstein SD; Schulman EA; Hopkins MM Headache; 1991 Sep; 31(8):525-32. PubMed ID: 1960057 [TBL] [Abstract][Full Text] [Related]
28. [Double blind study of migraine therapy with etilefrine pivalate]. Cruz A; Bühling M; Seibel K Arzneimittelforschung; 1985; 35(7):1086-9. PubMed ID: 2864937 [TBL] [Abstract][Full Text] [Related]
29. [Possibility of timolol use for immediate alleviation of Horton's cluster headache. Preliminary report]. Prusiński A Neurol Neurochir Pol; 1980; 14(2):191-3. PubMed ID: 6993977 [TBL] [Abstract][Full Text] [Related]
30. Exacerbation of SUNCT and SUNA syndromes during intravenous dihydroergotamine treatment: A case series. Lambru G; Shanahan P; Matharu M Cephalalgia; 2015 Oct; 35(12):1115-24. PubMed ID: 25667300 [TBL] [Abstract][Full Text] [Related]
32. Planned release dihydroergotamine in common migraine and "tension-vascular headache": multicentre clinical trial. Fontanari D; Perulli L; Conte F; Tambato E; Toso V; Zanetti R Cephalalgia; 1983 Aug; 3 Suppl 1():189-91. PubMed ID: 6352048 [TBL] [Abstract][Full Text] [Related]
33. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. Aurora SK; Rozen TD; Kori SH; Shrewsbury SB Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249 [TBL] [Abstract][Full Text] [Related]
34. Dihydroergotamine: role in the treatment of migraine. Schürks M Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283 [TBL] [Abstract][Full Text] [Related]
35. [Atropine preparations in the treatment of Horton's headache]. Split W; Szmidt M Wiad Lek; 1984 Sep; 37(18):1417-20. PubMed ID: 6397917 [No Abstract] [Full Text] [Related]
36. Histamine skin test in cluster headache: effects of dihydroergotamine with timed release. Giacovazzo M; Romiti A; Martelletti P; Gallo MF; Megale G Cephalalgia; 1983 Aug; 3 Suppl 1():171-4. PubMed ID: 6616600 [TBL] [Abstract][Full Text] [Related]
38. [Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks]. Pradalier A; Guérard des Lauriers A; Scheck F; Peraudeau P; Lacoste JP; Cajfinger F Pathol Biol (Paris); 1995 Nov; 43(9):806-13. PubMed ID: 8746103 [TBL] [Abstract][Full Text] [Related]
39. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235 [TBL] [Abstract][Full Text] [Related]